Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tramadol Injections for Anaesthetic Success in Irreversible Pulpitis
NCT05538052Completed
- Sponsor
- Jamia Millia Islamia
- Start
- Apr 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tramadol in irreversible pulpitis (3 arms), sponsored by Jamia Millia Islamia. Primary endpoint: Anesthetic success rate. Started Apr 2022; status: completed.
02
Drugs
tramadol
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT05538052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05538052.